Summary: *Content warning: Suicide*
Smoky Mountain News explores MAPS’ expanded access program for MDMA-assisted therapy for treatment-resistant PTSD by interviewing Dr. Raymond Turpin of Pearl Psychedelic Institute, an expanded access site located in Waynesville, North Carolina.
Additionally, SGT(R) Jonathan Lubecky shares his personal experience as a participant in MAPS’ Phase 2 clinical trial of MDMA-assisted therapy for PTSD.